The determination of hexosaminidases A and B in most programmes for Tay-Sachs disease camer detection is based on their different heat sensitivity (hexosaminidase A is the heat labile isoenzyme). This routine cannot be employed for individuals who also possess a therrnolabile hexosaminidase B. In Israel, 0.6% of the screened samples have a labile hexosaminidases B (about 110 each year) and the assessment of their hexosaminidase A activity has hitherto been based on isoenzyme Separation by ion exchange chromatography. The latter requires relative large serum samples, and the individuals must usually be reappointed. In order to avoid the thermal treatment we have used the alternative technique, which employs two Substrates with different specificities for the two isoenzymes:
Introduction
encoded at two independent loci. Hexosaminidase A is -u · .r *u ^ *-£· L. · -responsible for the degradation of GM2-ganglioside (2-The basis for the routine estimation of hexosaminidase r ., , , ft ^ , AOactivity.asameaosofscreeningforr^-^^car-acetamido 2-deoxy-D-galactopyranose ßl-4-galactoriers, is the different heat stability of the two main iso-syl[3-2a-N-acetyl neuraminic acid]-ßl-4-glucosylceraenzymes, hexosaminidase A and hexosaminidase B. inidase B isoenzyme thermolabile (TLB) (2-4). Hetero-zygotes and homozygotes for thal trait have been identified and appearcd to be healtliy (5) . An individual who is a heterozygote for both mutations (thermolabile hexosaminidase B and Tay-Sachs), might be misdiagnosed s a non-carrier of the Tay-Sachs gene. During the thermal treatment, hexosaminidase A and pari of hexosaminidase B will be inactivated and the final heat labile fraction might appear normal. Currently, hexosaminidase A and hexosaminidase B are separated by ion exchange chromatography and the genotypes are determined according to their final proportions, s previously described (3, 4) . The latter technique employs a relative large serum sample (5) and the subjects suspected of carrying a labile hexosaminidase B gene are compelled to be reappointed for a second sample. During 1987-1992, 600 individuals surveyed for the Tay-Sachs gene (0.59%) were suspected to be thermolabile hexosaminidase B carriers (having less than 23% of serum heat stable activity).
In the present study we used an alternative method, previously described to be appropriate for Tay-Sachs carrier detection, which avoids the heating Step (6) (7) (8) . It employs two different enzymatic assays for each serum sample. Hexosaminidase A activity (measured with the specific Substrate, 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate) is expressed s a fraction of total activity, measured with the common Substrate, 4-methylumbelliferyl-N-acetyl-glucopyranoside. We analysed the distribution of hexosaminidase A levels using the latter procedure in 65 obligate Tay-Sachs disease hetero* zygotes, and were accordingly able to determine the reference ranges for the assignment of the genotypes of the Tay-Sachs allele (9, 10) . By using the double Substrate strategy the first drawn sample was sufficient and the thermolabile hexosaminidase B carriers were absolved from additional tests and anxiety.
Materials and Methods
The study covers 101690 Jews whose sera were screened for hexosaminidase A level, s part of the national programme for TaySachs disease carrier detection (1987) (1988) (1989) (1990) (1991) (1992) . Serum samples were routinely analysed by an automated System (Technicon autoanalyzer II) which dil ted, heat inactivated and assayed hexosaminidase activity (11) using the fluorogenic Substrate 4-methylumbelliferyl-N-acetyl-glucopyranoside (Genzyme Fine Chemicals, U.K.). Hexosaminidase A activity was defined s percent of total hexosaminidase activity lost by heating. For ion exchange chromatography, 2-3 ml of dialysed serum were applied to a DE52 (Whatman, U.K.) column (0.5 X 5cm). The effluent contained hexosaminidase B, while hexosaminidase A was eluted with 0.3 mol/1 NaCl s described (3, 12) . Each fraction was assayed (13) and the fluorescence was read in a LS-5B Perkin Eimer lurninescence spectrometer (U. K.). The overall activity of each isolated isoenzyme was calculated and the genotype was determined according to their final proportions (3) . A control serum with a volume identical to the examined sample was used with every run The manual assay with 4^methylumbelliferyl-N-acetyl glucosamine-6-sulphate was basically s previously described (6, 7) with somc modifications s follows: 200 μΐ of 3 g/l 4-methylurnbelliferyl-N-acetyl glucosamine-6-sulphate (Research Development Corporation, Canada) in 50 mmoI/J citrate buffer pH 4.2 were added to 100 μΐ aliquots of l : 10 dil ted serum (in the same buffer) and incubated for 90 min at 37 °C. The manual assay measuring total activity with 4-methylumbelliferyl-N-acetyl-gIucopyranoside (without heating) was carried out at thepme time, using the same dil ted serum (13) . The enzymatic activity with 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate was expressed either s μτηοΐ/min -l serum or s the ratio of total activity (6,7). A constant Standard was assessed with every run and the activity ratio of each sample was corrected according to the ratio of the Standard. In addition a Tay-Sachs patient sample was routinely assayed with the 2 Substrates. The limits for the Tay-Sachs genotype assignment were determined according to the r nge of values and the variance of 65 obligate heterozygotes s previously described (9, 10) . Hexosaminidase B heat sensitivity was determined with an aliquot of 0.3-0.5 ml of the original serurn sample using a 0.5 X l ml DE52 column. The effluent containing the hexosaminidase B fraction (3, 12) was heated for 3 h at 50 °C after adjustinent of the pH to 5.0 (by addition of about 10 μg of citric acid) and the addition of l g/l bovine serum albumin (13) .
Results
Under our Standard conditions, the enzymatic assay with 4-methylurnbelliferyl-N-acetyl glucosamine-6-sulphate was linear for more than 2 h (7), with normal sera and with sera from carriers (data not shown). Serum samples (n = 150), previously tested by the routine automated method, were examined by the manual direct assay with 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate. Figure l shows the distribution of hexosaminidase A values, expressed s μπιοΐ/min · 1. The mean activity (± SD) of 59 normal sera was 1.49 ± 0.29 μπιοΐ/ιηίη · l, the average value of 65 obligate heterozygotes was 0.79 ± 0.21 μπιοΐ/min · l, and the values of 26 "incoiicltisive" sera (border line values which could not be desig·n ated s carriers or homozygote normals) were seattered between those of normals and heterozygotes. As already reported (7, 8) , this technique is appropriate for TaySachs carrier scfeening. In the present conditions there was a significant difference (p < 10~5, t-test) between hexosaminidase A mean values of non-carriers and carr iers (7, 8) . Nevertheless, when individuals bearing the TLB gene were similarly screened (61), they were falsely categorized s carriers ( fig. 1) , having a mean activity value of 0.95 ±0.16 μιηοΐ/min · l (not significantly different from that of the heterozygotes). All the TLB suspected sera were previously diagnosed s noncarriers by the ion exchange chromatography routine.
Entirely different results were obtained when the same hexosaminidase A activity (assayed with 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate) was expressed s a fraction of total activity, measured with 4-methylumbelliferyl-N-acetyl·glucopyranoside (without heating). The distribution of hexosaminidase A values expressed s ratios is shown in figure 2 . Hexosaminidase A activities of the TLB-carriers were within the normal r nge ( s expected). The mean ratios of the 3 genotypes were: 1.43 ± 0.099 for homozygpte normals, 1.48 ΐ 0.1 for the 61 TLB individuals and 0.88 ±0.17 for Tay-Sachs obligate heter zygotes, the latter value being significantly different from those of the other 2 groups (p < l O"" 6 , t test and variance analysis).
The inter-assay coefficient of Variation of the double Substrate technique (ratio) was 11% (N = 11), which is much smaller than that of the ion exchange chromato graphy procedure (21%, N = 12) . The activity of hexosaminidase A s expressed by the ratio mode, exhibited a normal Gaussian disttibution (data not shown) similar to the distributioii displayed by the conventional heat fractionation method. Thus, we used the same approach to assign the genotypes for the Tay-Sachs locus (9, 10) . Individuals with a ratio of 1.11 and lower were designated s carriers of the Tay-Sachs allele, those with a value higher than 1.29 being designated s homozygotes for the normal allele, while values in-between were defined s inconclusive. The maximal hexosaminidase A activity found in the sera of Tay-Sachs patients was 0.07
Tab. l Corrclation of the results obtained by the conventional heat inactivation and 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate/4-methylumbelliferyl-N-acetyl-glucopyranoside ratio methods. Diagnoses of the TLB allele obtained by the use of 0.3-0.5 ml of serum were in complete agreement with those obtained by the routine column Separation, which employed 2-3 ml (8). Hexosaminidase B fractions of normal sera eluted from the routine ion exchange column (100 sera) and from the micro column (56 sera), exhibited residual heat stable activity of 91.8% ± 13.6 and 90.8% ± 5.6 respectively. Based on the latter averages and tolerance ranges, we designated individuals with more than 20% heat labile hexosaminidase B äs carriers of the TLB gene (very similar to the estimate previously reported, (14) ). Eighty sera were diagnosed identically by the two ion exchange procedures and by the hexosaminidase B residual heat stable activity values, with a correlation of r = 0.963.
Discussion
About 0.6% of the individuals attending the Israeli national Programme for Tay-Sachs carrier detection are suspected of carrying the TLB gene. Hexosaminidase A activity in those cases was routinely measured by ion exchange chromatography, avoiding the heating step. According to the Standard procedure (5, 7) the optimal volume of dialysed serum for application to the column was 2-3 ml. Smaller samples resulted in large intrabatch variations (24%-35%) of the final ratio of hexosaminidase A to hexosaminidase B. Since the first drawn sample was not always sufficient for column Separation, individuals suspected of carrying the TLB allele (about 600 during 6 years) had to be retested. The modified method, practiced in the present study, employs 0.4-0.5 ml serum for the determination of both genötypes. This volume öf serum was sufficient for evaluating hexosaminidase A activity and hexosaminidase B heat lability.
It has been reported that total hexosaminidase A activity is consistently lower in the serum of TLB carriers (15) . In our laboratory the mean total tipxosaminidase activity of 110 sera with TLB äs well äs their mean hexosaminidase A activity were about 60% of normal. The decreased hexosaminidase A activity in these individuals stemmed from the overall lower hexosaminidase levels and was not due to a Imitation in the subunit löcus. Nevertheless, the original proportions of the main isoenzymes seemed to be sustained, leading to normal activity ratios of hexosaminidase A to total hexosaminidr äse ( fig. 2) . The ratio method for detecting hexosaminidase A deficiency is inaccurate when applied to sera from pregnant women, or to the sera of certain inconclusive cases, where the proportions of the various isoenzymes are altered. Several studies report TLB to possess decreased assembly capability and decreased molecular stability (16, 17) , which probably account for the overall lower measured activity. Since it is not yet clear how many alleles exist for the trait and to what extent hexosaminidase B lability is induced, it is conceivable that some cases with very mild thermolabile hexosaminidase B will be missed by our screening policy. In most reported cases and even in a case of a homozygote for the mutation (5, 16), a functional hexosaminidase A can be detected, with sufficient activity to prevent GM2 gangliosidosis. None of the individuals diagnosed through our screening program reported any Symptoms when filling out the routine questionnaire before sampling.
The great majority of TLB Jewish carriers originate in Asia (14) : Iraq, Iran, Syria, India and Turkey. This mutation was found to be extremely rare among Eastern European Jews -(only one in about 50000), the ethnic groups among which the Tay-Sachs gene is found in substantial frequency. These data are compatible with a previous report which covered the years 1982-1986 (8) .
During the last few years there has been a consistent increase in the number of -Ashkenazi and mixed origin Jews attending the sereening programme (during 1991 only one third of the screened individuals were Eastern European). Thus the chaiice of häving an iridividual with both mutations is increasing constantly. It is essential to be alert to any unusual serum sample and if necessary to reassay the sample with 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate, which provides a fast and reliable determination of hexosaminidase A activity. Bur 
